Searching…
YONSA ® (abiraterone acetate) in combination with methylprednisolone is indicated for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC).
2025年12月1日 · Methylprednisolone is a corticosteroid that must be taken to reduce the chance of developing low blood pressure, heart effects or low levels of potassium in your blood while you are …
In the active treatment arms, abiraterone acetate was administered at a dose equivalent to 500 mg of YONSA (abiraterone acetate tablets contained in YONSA MPRED) once daily in combination with …
2025年9月4日 · Yonsa is used together with a steroid medicine (prednisone or methylprednisolone) to treat prostate cancer that has spread to other parts of the body (metastatic) and cannot be treated …
On this page about Yonsa Mpred you will find information relating to side effects, age restrictions, food interactions, whether the medicine is available at a government subsidised price on the …
Depending on your condition, the usual dose of the methylprednisolone 4 mg tablets in the YONSA MPRED pack is either one tablet once a day or one tablet twice a day.
Yonsa is a drug used to treat metastatic prostate cancer in men. Women should not ever take or even handle the drug, especially if pregnant. It's meant to be used methylprednisolone.
YONSA MPRED is a combination pack which contains two different medicines, YONSA tablets and Methylprednisolone tablets. YONSA tablets contain the active ingredient abiraterone acetate and …
2026年1月4日 · YONSA is indicated in combination with methylprednisolone for the treatment of patients with metastatic castration-resistant prostate cancer.
2024年10月13日 · Overview: Yonsa is used for certain types of prostate cancer. Common side effects include hot flashes, diarrhea, and joint swelling or pain. Yonsa interacts with several medicines. Be …
